Country: United States
Language: English
Source: NLM (National Library of Medicine)
AZELASTINE HYDROCHLORIDE (UNII: 0L591QR10I) (AZELASTINE - UNII:ZQI909440X)
Somerset Therapeutics, LLC
OPHTHALMIC
PRESCRIPTION DRUG
Azelastine hydrochloride is indicated for the treatment of itching of the eye associated with allergic conjunctivitis. Azelastine hydrochloride is contraindicated in persons with known or suspected hypersensitivity to any of its components.
Azelastine hydrochloride ophthalmic solution, 0.05% is supplied as follows: 6 mL (NDC # 70069-091-01) solution in 10 mL natural HDPE bottle plugged with natural LDPE nozzle and white HDPE screw cap. Storage Store UPRIGHT between 2° and 25°C (36° and 77°F). Rx only For Product Inquiry call +1-800-417-9175 Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024 Made in India Code No.:KR/DRUGS/KTK/28/289/97 Issued: December, 2019 ST-AZL11/P/02 PSSO0480
Abbreviated New Drug Application
AZELASTINE HYDROCHLORIDE - AZELASTINE HYDROCHLORIDE SOLUTION/ DROPS SOMERSET THERAPEUTICS, LLC ---------- AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION, 0.05% SOMERSET THERAPEUTICS, LLC DESCRIPTION Azelastine hydrochloride ophthalmic solution, 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H -receptor antagonist for topical administration to the eyes. Azelastine hydrochloride is a white crystalline powder with a molecular weight of 418.37. Azelastine hydrochloride is sparingly soluble in water, methanol and propylene glycol, and slightly soluble in ethanol, octanol, and glycerine. Azelastine hydrochloride is a racemic mixture with a melting point of 225°C. The chemical name for azelastine hydrochloride is (±)-1-(2H)-phthalazinone,4-[(4- chlorophenyl) methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-, mono hydrochloride and is represented by the following chemical structure: Empirical chemical structure: C H ClN O•HCl Each mL of Azelastine hydrochloride ophthalmic solution contains: ACTIVE: 0.5 mg azelastine hydrochloride, equivalent to 0.457 mg of azelastine base; PRESERVATIVE: 0.125 mg benzalkonium chloride; INACTIVES: disodium edetate dihydrate, hypromellose, sorbitol solution, sodium hydroxide and water for injection. It has a pH of approximately 5.0 to 6.5 and an osmolarity of approximately 271 to 312 mOsmol/L. CLINICAL PHARMACOLOGY Azelastine hydrochloride is a relatively selective histamine H antagonist and an inhibitor 1 22 24 3 1 of the release of histamine and other mediators from cells (e.g. mast cells) involved in the allergic response. Based on in-vitro studies using human cell lines, inhibition of other mediators involved in allergic reactions (e.g. leukotrienes and PAF) has been demonstrated with azelastine hydrochloride. Decreased chemotaxis and activation of eosinophils has also been demonstrated. PHARMACOKINETICS AND METABOLISM Absorption of azelastine following ocular administration was relatively low. A study in symptomatic patients receiving Read the complete document